Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Soleno Therapeutics Inc (SLNO)

Soleno Therapeutics Inc (SLNO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,616
  • Shares Outstanding, K 120,089
  • Annual Sales, $ 0 K
  • Annual Income, $ -30,910 K
  • 60-Month Beta 0.24
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.79
Trade SLNO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.25
  • Most Recent Earnings -0.07 on 05/10/22
  • Next Earnings Date 08/10/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( -446.38%)
  • Historical Volatility 87.26%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 1,436.47% on 01/19/22
  • IV Low 0.00% on 08/08/22
  • Put/Call Vol Ratio 0.25
  • Today's Volume 5
  • Volume Avg (30-Day) 25
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 5,662
  • Open Int (30-Day) 5,663

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.07
  • Number of Estimates 1
  • High Estimate -0.07
  • Low Estimate -0.07
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1600 +11.31%
on 08/02/22
0.2770 -35.70%
on 07/20/22
-0.0366 (-17.05%)
since 07/08/22
3-Month
0.1302 +36.79%
on 05/12/22
0.2770 -35.70%
on 07/20/22
+0.0081 (+4.76%)
since 05/06/22
52-Week
0.1302 +36.79%
on 05/12/22
0.9789 -81.81%
on 08/09/21
-0.7819 (-81.45%)
since 08/06/21

Most Recent Stories

More News
Soleno Therapeutics Announces Presentation of DCCR Data at the 11th International Prader-Willi Syndrome Organisation Conference

REDWOOD CITY, Calif., July 11, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...

SLNO : 0.1781 (-1.06%)
Here's Why Viracta Therapeutics (VIRX) is Up So Far This Year

Viracta Therapeutics' (VIRX) Nana-val is being evaluated in multiple clinical studies in various subtypes of EBV-associated cancers.

SLNO : 0.1781 (-1.06%)
ASRT : 3.65 (-8.52%)
KDNY : 20.49 (+0.24%)
VIRX : 3.95 (+2.07%)
Here's Why Assertio Holdings (ASRT) Stock is Up This Year

Assertio Holdings' (ASRT) successful execution of its restructuring plan, resulting in significant cost savings, is boosting profits.

SLNO : 0.1781 (-1.06%)
ASRT : 3.65 (-8.52%)
KDNY : 20.49 (+0.24%)
VIRX : 3.95 (+2.07%)
Zacks Industry Outlook Highlights Chinook Therapeutics, Assertio Holdings, Viracta Therapeutics and Soleno Therapeutics

Chinook Therapeutics, Assertio Holdings, Viracta Therapeutics and Soleno Therapeutics are part of Zacks Industry Outlook article.

SLNO : 0.1781 (-1.06%)
ASRT : 3.65 (-8.52%)
KDNY : 20.49 (+0.24%)
VIRX : 3.95 (+2.07%)
4 Small Stocks to Bet on in an Upbeat Drugs Industry

It is expected that innovation will continue to drive growth in the Medical-Drugs industry in 2022. KDNY, ASRT, VIRX, SLNO may prove to be good additions to one's portfolio.

KDNY : 20.49 (+0.24%)
SLNO : 0.1781 (-1.06%)
ASRT : 3.65 (-8.52%)
VIRX : 3.95 (+2.07%)
Soleno Therapeutics Presents Long Term Data for DCCR Showing Metabolic and Body Composition Improvements in Patients with PWS

Patients demonstrated statistically significant improvements in several hormonal and cardiometabolic parameters following treatment with DCCR...

SLNO : 0.1781 (-1.06%)
Soleno Therapeutics Announces Presentations at ENDO 2022

REDWOOD CITY, Calif., June 07, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...

SLNO : 0.1781 (-1.06%)
Soleno Therapeutics Announces Presentations at the 2022 European Congress of Endocrinology

REDWOOD CITY, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company...

SLNO : 0.1781 (-1.06%)
KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M

KemPharm (KMPH) inks deal to acquire Orphazyme A/S, which will add to its portfolio the latter's pipeline candidate, arimoclomol, being developed for treating Niemann-Pick disease type C. Shares rise.

KMPH : 5.97 (-7.30%)
ACRS : 18.00 (unch)
SLNO : 0.1781 (-1.06%)
VRCA : 3.42 (+1.18%)
Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug

The FDA accepts Regulus' (RGLS) IND application for RGLS8429 to treat autosomal dominant polycystic kidney disease. The company plans to begin a phase I study in second-quarter 2022. Stock up.

SNY : 49.08 (-1.27%)
RGLS : 1.7700 (+9.94%)
ONTX : 1.3400 (-7.59%)
SLNO : 0.1781 (-1.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief....

See More

Key Turning Points

3rd Resistance Point 0.2022
2nd Resistance Point 0.1951
1st Resistance Point 0.1866
Last Price 0.1781
1st Support Level 0.1710
2nd Support Level 0.1639
3rd Support Level 0.1554

See More

52-Week High 0.9789
Fibonacci 61.8% 0.6547
Fibonacci 50% 0.5545
Fibonacci 38.2% 0.4544
Last Price 0.1781
52-Week Low 0.1302

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar